Our home market.
Building regulatory readiness and qualified supply pathways. Required MHRA authorisations and GDP operating controls must precede regulated supply.
International markets
We identify product opportunities, assess local regulatory pathways and develop qualified partnerships for access to medicines across global markets.
Target markets. Local responsibility.
Product-specific opportunities. Local permissions first.
Building regulatory readiness and qualified supply pathways. Required MHRA authorisations and GDP operating controls must precede regulated supply.
Exploring member-state opportunities through locally authorised partners. UK wholesale permissions do not transfer to EU member states.
Evaluating state-specific licensing and commercial partnerships. Applicable state licences and DSCSA requirements govern prescription wholesale activities.
Assessing importer, distributor and product-specific routes. Drug, device and natural-health-product requirements remain distinct.
Considering country-specific partnerships, including the UAE and Saudi Arabia. Establishment, import and distribution permissions require local assessment.
These are markets under evaluation, not claims of active regulated pharmaceutical distribution or existing wholesale authorisations across these territories.
Expansion discipline
For each target market, we assess demand, regulatory requirements, authorised counterparties, commercial viability, product evidence and accountable supply arrangements.
Current regulatory boundary. Regulated pharmaceutical wholesale supply has not commenced. Any future supply depends on required local authorisations, product-specific permissions, qualified suppliers, GDP/quality controls and permitted buyer channels. UK permissions do not confer distribution rights in other countries.
Explore our market-entry approachTell us the product and the market. We will explore the pathway with evidence.
Start a qualified conversationFor qualified B2B organisations. An enquiry is not an offer to supply, an approval or a guarantee of market availability.